Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tagariello

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 6, 2007
F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitorsR Salviato, D Belvini, P Radossi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2009
Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia AV Bafunno, R Santacroce, M Chetta, et al.
Haematologica|May 1, 1988
Absence of HBV-DNA in serum of hemophilic carriers of hepatitis B surface antigen with chronic liver diseaseG Tagariello, A Dal Canton, G Davoli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2013
Prenatal diagnosis of haemophilia B: the Italian experienceD Belvini, R Salviato, M Acquila, et al.
European Review for Medical and Pharmacological Sciences|May 2, 2023
Topical hemostatic agents in oral surgery: a narrative reviewA Scarano, L Leo, F Lorusso, et al.
Blood|May 15, 1997
A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia CentersM G Rumi, E Santagostino, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 19, 2016
Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian studyM Morfini, A Dragani, E Paladino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2018
"In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrateC Bulato, C Novembrino, M Boscolo Anzoletti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 13, 2006
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia AM Franchini, D Girelli, O Olivieri, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2018
Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophiliaR A Gruppo, D Malan, J Kapocsi, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 6, 2007
F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitorsR Salviato, D Belvini, P Radossi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2009
Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia AV Bafunno, R Santacroce, M Chetta, et al.
Haematologica|May 1, 1988
Absence of HBV-DNA in serum of hemophilic carriers of hepatitis B surface antigen with chronic liver diseaseG Tagariello, A Dal Canton, G Davoli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2013
Prenatal diagnosis of haemophilia B: the Italian experienceD Belvini, R Salviato, M Acquila, et al.
European Review for Medical and Pharmacological Sciences|May 2, 2023
Topical hemostatic agents in oral surgery: a narrative reviewA Scarano, L Leo, F Lorusso, et al.
Blood|May 15, 1997
A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia CentersM G Rumi, E Santagostino, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 19, 2016
Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian studyM Morfini, A Dragani, E Paladino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2018
"In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrateC Bulato, C Novembrino, M Boscolo Anzoletti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 13, 2006
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia AM Franchini, D Girelli, O Olivieri, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2018
Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophiliaR A Gruppo, D Malan, J Kapocsi, et al.
Pageof 6